A Shetlander’s courageous decision to walk the catwalk for charity has highlighted the life-saving potential of proactive genetic screening, and is poised to galvanize further support for a groundbreaking community-wide genetic testing program in the islands. Christine Glaser’s story isn’t just one of personal bravery in the face of a cancer diagnosis; it’s a powerful illustration of how early detection, facilitated by initiatives like the Viking Genes program, can dramatically alter outcomes.
- Early Detection Saves Lives: Glaser’s cancer was discovered *before* symptoms appeared, avoiding the need for aggressive treatments like chemotherapy.
- Genetic Predisposition: The case underscores the importance of understanding familial genetic risks, particularly the BRCA2 gene variant prevalent in the Whalsay community.
- Fundraising Momentum: Glaser’s participation in “Courage on the Catwalk” is expected to significantly boost fundraising for both Friends of Anchor and the Viking Genes program.
The Viking Genes program, launched in response to a recognized higher incidence of certain cancers within the Shetland population, offers genetic testing to identify individuals carrying genes like BRCA2, which significantly increase the risk of breast and ovarian cancer. Glaser’s experience is a compelling example of its efficacy. While she initially opted for preventative surgery after discovering she carried the gene, preliminary tests revealed existing cancer, allowing for early intervention. Without the program’s proactive outreach, her mammogram would have been two years later, potentially leading to a far more challenging treatment journey.
The prevalence of the BRCA2 variant within the Whalsay community is particularly noteworthy. Glaser reports that five out of six siblings carry the gene, and her sister tragically succumbed to ovarian cancer. This concentrated genetic risk underscores the need for targeted screening programs, and the potential for Viking Genes to become a model for other communities with similar genetic predispositions.
The Forward Look
Glaser’s fundraising efforts for Friends of Anchor are immediate and impactful, providing vital support to cancer patients across the north of Scotland. However, the longer-term implications center on the future of the Viking Genes program. The program is currently aiming to raise £1 million to fund a comprehensive genetic screening initiative for 5,000 Shetlanders – a project that would be the first of its kind in Scotland. Glaser’s commitment to organizing a further fundraiser in Shetland next year will be crucial in maintaining momentum.
Success in Shetland could pave the way for similar community-based genetic screening programs elsewhere in the UK, and potentially internationally. The ethical considerations surrounding widespread genetic testing – including data privacy and potential psychological impact – will need careful consideration, but the potential benefits in terms of early detection and preventative care are substantial. The spotlight on Glaser’s story, and the success of the Viking Genes program, will undoubtedly fuel this debate and accelerate the adoption of proactive genetic screening as a key component of public health strategy.
You can donate to Glaser’s JustGiving page for Friends of Anchor here.
Related reading
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.